Evidence map›Paper›PMID 26462276›Full record

ArticleBMJ open gastroenterology2015

Inflammation decreases keratin level in ulcerative colitis; inadequate restoration associates with increased risk of colitis-associated cancer.

Bernard M Corfe, Debabrata Majumdar, Arash Assadsangabi, Alexandra M R Marsh, Simon S Cross, Joanne B Connolly, Caroline A Evans, Alan J Lobo

Open access · goldAbstract read
In one paragraph

Article in BMJ open gastroenterology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Keratin 1 modulates intestinal barrier and immune responseWorld journal of gastroenterology · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Roles of Keratins in Intestine.International journal of molecular sciences · 2022
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Bernard M CorfeMolecular Gastroenterology Research Group, Academic Unit of Surgical Oncology, Department of Oncology , University of Sheffield, The Medical School , Sheffield , UK ; Insigneo Institute for in silico Medicine, University of Sheffield , Sheffield , UK.
Debabrata MajumdarMolecular Gastroenterology Research Group, Academic Unit of Surgical Oncology, Department of Oncology , University of Sheffield, The Medical School , Sheffield , UK ; Gastroenterology Unit , Royal Hallamshire Hospital , Sheffield , UK.
Arash AssadsangabiMolecular Gastroenterology Research Group, Academic Unit of Surgical Oncology, Department of Oncology , University of Sheffield, The Medical School , Sheffield , UK ; Gastroenterology Unit , Royal Hallamshire Hospital , Sheffield , UK.
Alexandra M R MarshMolecular Gastroenterology Research Group, Academic Unit of Surgical Oncology, Department of Oncology , University of Sheffield, The Medical School , Sheffield , UK ; Gastroenterology Unit , Royal Hallamshire Hospital , Sheffield , UK.
Simon S CrossAcademic Unit of Pathology, Department of Neuroscience, Faculty of Medicine, Dentistry & Health , University of Sheffield , Sheffield , UK.
Joanne B ConnollyWaters Corporation , Wilmslow , UK.
Caroline A EvansBiological and Systems Engineering Group, Department of Chemical and Biological Engineering , ChELSI Institute, University of Sheffield , Sheffield , UK.
Alan J LoboMolecular Gastroenterology Research Group, Academic Unit of Surgical Oncology, Department of Oncology , University of Sheffield, The Medical School , Sheffield , UK ; Gastroenterology Unit , Royal Hallamshire Hospital , Sheffield , UK.
University of Sheffield · GBInsigneo · GBRoyal Hallamshire Hospital · GBWaters (United Kingdom) · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundKeratins are intermediate filament (IF) proteins, which form part of the epithelial cytoskeleton and which have been implicated pathology of inflammatory bowel diseases (IBD).

methodsIn this study biopsies were obtained from IBD patients grouped by disease duration and subtype into eight categories based on cancer risk and inflammatory status: quiescent recent onset (<5 years) UC (ROUC); UC with primary sclerosing cholangitis; quiescent long-standing pancolitis (20-40 years) (LSPC); active colitis and non-inflamed proximal colonic mucosa; pancolitis with dysplasia-both dysplastic lesions (DT) and distal rectal mucosa (DR); control group without pathology. Alterations in IF protein composition across the groups were determined by quantitative proteomics. Key protein changes were validated by western immunoblotting and immunohistochemical analysis.

resultAcute inflammation resulted in reduced K8, K18, K19 and VIM (all p<0.05) compared to controls and non inflamed mucosa; reduced levels of if- associated proteins were also seen in DT and DR. Increased levels of keratins in LSPC was noted relative to controls or ROUC (K8, K18, K19 and VIM, p<0.05). Multiple K8 forms were noted on immunoblotting, with K8 phosphorylation reduced in progressive disease along with an increase in VIM:K8 ratio. K8 levels and phosphorylation are reduced in acute inflammation but appear restored or elevated in subjects with clinical and endoscopic remission (LSPC) but not apparent in subjects with elevated risk of cancer.

conclusionsThese data suggest that keratin regulation in remission may influence subsequent cancer risk.

Indexed as

CYTOKERATINSDYSPLASIAGUT INFLAMMATIONULCERATIVE COLITIS

Identifiers

PMID26462276
PMCPMC4599170
OpenAlexW1947074225

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.